Merck no longer in talks to buy Revolution Medicines, WSJ reports-March 2024-www.financetom.com

Merck no longer in talks to buy Revolution Medicines, WSJ reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Merck no longer in talks to buy Revolution Medicines, WSJ reports

Mar 11, 2026 1:33 AM

Jan 25 (Reuters) - Merck ( MRK ) is ‌no longer in

discussions ‍to buy ⁠Revolution ⁠Medicines, ‌the Wall

Street Journal ⁠reported ‍on Sunday, citing people familiar ‍with

the matter.

Reuters could not ‍immediately verify the report.

Previous page： 10 key things to know about RBI’s MSME recommendations Next page： Supreme Court issues new roster system, to be followed from July 1

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

10 key things to know about RBI’s MSME recommendations

Jun 25, 2019

The Reserve Bank of India (RBI) has recommended a government-sponsored fund of Rs 10,000 crore to support investments made in micro, small and medium enterprises (MSMEs).

Supreme Court issues new roster system, to be followed from July 1

Jun 26, 2019

The Supreme Court on Wednesday issued a new roster system which will be followed after the apex court re-opens on July 1.

Total debt of Air India is Rs 58,351 crore, says government

Jun 26, 2019

Last year, the centre had invited Expression of Interest for strategic disinvestment of Air India, including its shareholding in Air India Express and Air India Air Transport Services Limited. However, it did not receive any bid till the last date on May 31, 2018.

RBI issues guidelines for setting up financial benchmark administrators

Jun 26, 2019

The Reserve Bank of India (RBI) on Wednesday issued guidelines for setting up of financial benchmark administrator (FBA) for administering "significant benchmarks" in the markets for financial instruments.